AUT

Autoimmune Panel

An autoimmune panel looks like a row of pass/fail antibodies but works as a cascade: an over-sensitive screen on top, disease-naming antibodies below it, and one pair that drops exactly when disease gets worse.

Read the Autoimmune Panel guide

A row of autoimmune antibodies on a lab report looks like a checklist: each one positive or negative, pass or fail. It behaves more like a cascade. One deliberately over-sensitive test sits at the top, and a branching set of narrower tests sits below it, ordered only when the screen at the top trips. The result people fixate on, a positive ANA, is the least conclusive line on the page. And tucked among markers that climb when disease is active is one pair that does the reverse, falling exactly as things get worse.

That shape is why the panel rewards reading it as a sequence rather than a scorecard. The marker cards below cover each antibody on its own. This page is about how they hand off to each other: which result opens which door, which combinations name a disease, and the one place the usual up-means-bad rule flips.

Why a positive ANA isn't the answer

The ANA test is the gate, and it is built to swing open easily. The design choice is deliberate: it would rather flag a harmless trace than miss a real autoimmune disease, so it is tuned for sensitivity over precision. The cost of that tuning is a flood of positives that mean little. The American College of Rheumatology puts it in numbers: only about 11 to 13 percent of people with a positive ANA actually have lupus or any autoimmune or connective tissue disease, and up to 15 percent of completely healthy adults test positive. A low-titer positive in someone who feels well is, more often than not, just background. Still, one line on the panel, anti-SSA (Ro), deserves special attention in anyone who is pregnant or planning, because the antibody can cross the placenta and affect the fetal heart.

So a positive ANA is a question, not a verdict. What answers it is the layer underneath: the specific antibodies that each lean toward a particular disease, often ordered together as the extractable nuclear antigen panel, plus complement levels and the antibodies that work the rheumatoid and vasculitis branches. The combinations are where the panel earns its place, because a single antibody rarely carries a diagnosis and a pattern often does. The panel also screens for antiphospholipid antibodies, where a single positive often fades on retesting while triple positivity carries a high risk of clots. Within the panel, the anti-Smith antibody is the specific-but-rare marker: negative in most people with lupus, yet near-conclusive when it does turn positive. Within this panel, the anti-centromere antibody stands out as one that can run ahead of symptoms, forecasting limited scleroderma in people who so far only have Raynaud's.

The combinations and what they usually mean

A positive ANA, and nothing else amiss

ANA · often low titer Specific antibodies Symptoms

The most common reason people arrive worried, and among the least likely to mean disease. The American College of Rheumatology notes most positive ANAs are not lupus, and that a meaningful share of healthy adults test positive at all. A lone, low-titer positive in someone who feels well is usually weighed against history and often simply monitored before it carries any weight.

Anti-dsDNA up while complement sinks

ANA Anti-dsDNA Complement C3 Complement C4

The active-lupus picture, and the one place the panel reads upside down. As anti-dsDNA antibodies climb, complement gets consumed clearing the wreckage, so C3 and C4 fall in step. MedlinePlus describes complement being used up during strong immune activity, which is why a rising antibody beside a dropping complement is read as active disease rather than two unrelated results.

Rheumatoid factor and anti-CCP both positive

Rheumatoid factor Anti-CCP

The rheumatoid-arthritis branch at its clearest. Rheumatoid factor on its own is loose, turning up in infections and healthy people, so a positive anti-CCP beside it carries far more weight than either alone. The two are read together precisely because anti-CCP is the more specific of the pair.

ANCA positive, by staining type

c-ANCA · or p-ANCA ANA

The vasculitis branch. MedlinePlus describes two staining types of anti-neutrophil antibody, c-ANCA and p-ANCA, with the lab reporting which is present to help identify the type of autoimmune vasculitis. The two lean toward different vasculitides, and p-ANCA can also appear in some inflammatory bowel disease, so the type narrows the question rather than closing it.

The marker that reads upside down

Most of the panel follows one intuition: more antibody means more disease. Complement breaks it. C3 and C4 are not autoantibodies but proteins the immune system spends, and in active lupus they get consumed faster than the body replaces them. So while anti-dsDNA is climbing, complement is sinking, and the meaningful finding is the gap opening between them. Read either number alone and the motion disappears; read them as a pair on the same draw and the flare becomes visible. It is the reason a rheumatologist orders anti-dsDNA, C3, and C4 together rather than reacting to any one of them. The panel pairs antibody tests with complement proteins, and a persistently low complement C4 is the result that can flag hereditary angioedema as well as lupus activity.

If your screen came back positive

  1. 1

    Start with the doctor who ordered it

    Ask what the ANA titer and pattern were, and whether your symptoms point anywhere. A high titer with classic symptoms and a low titer in someone who feels well are read very differently, and that context decides what, if anything, comes next.

  2. 2

    Let the specific antibodies do the naming

    The screen does not diagnose; the narrower antibodies lean toward particular diseases. Which ones are worth adding depends on the ANA pattern and the clinical picture, not on running every test at once.

  3. 3

    Read complement as a pair, and on the same draw

    A C3 or C4 in isolation says little. The information is in whether both fall together as an antibody rises, so they are most useful measured alongside anti-dsDNA rather than on their own.

  4. 4

    Watch the trend, not the single sheet

    Antibody titers drift and complement moves slowly. A series of draws read together tells your doctor more than any one report, which is why a borderline result is often repeated rather than acted on immediately.

What the panel can and can't do

Read as a whole, the panel is good at one thing and poor at another. It is good at branching: a positive screen routes toward the specific antibodies, those lean toward a disease, and complement and ANCA fill in whether something is active and where. It is poor at delivering a verdict from a single line. A positive ANA over-reports, a negative specific antibody does not clear the disease it tracks, and the total immunoglobulins like IgA and IgG measure the size of an antibody pool rather than what it is aimed at. None of these is a diagnosis by itself. Among the clotting-linked autoantibodies, the anticardiolipin antibody is notable because a single positive often fades and must be reconfirmed before it means anything. A perinuclear ANCA result, p-ANCA, often turns up on this panel and narrows the field toward vasculitis or inflammatory bowel disease without naming a single diagnosis. The panel also reports c-ANCA, whose cytoplasmic glow can flag possible ANCA-associated vasculitis once a PR3 immunoassay confirms it.

That is the throughline worth carrying off the page. The autoimmune panel is a sequence of questions, each result deciding which question gets asked next, and the answer almost never lives in one number. Myositis-specific antibodies such as anti-Jo-1 are usually run as part of this panel, since a patient is generally positive for only one of them. The guide to reading an autoimmune panel walks through how the screen, the specific antibodies, and complement are weighed together rather than one at a time.

Sources

Written and reviewed by BloodSight Editorial Team · Last updated

Tests in this panel

Lupus-specific

Anti-Smith Antibody

Anti-Sm

Highly specific for lupus when present, though found in only a minority of people who have it. A positive carries weight; a negative rules nothing out.

Adult Male index
0
0.9

The RA branch

Anti-Cyclic Citrullinated Peptide

Anti-CCP

More specific for rheumatoid arthritis than rheumatoid factor, and able to turn positive years before the first swollen joint. Read as the pair's confirming voice.

Adult Male U/mL
0
20

Consumed in active disease

Complement C3

C3

The most abundant complement protein. It is spent clearing immune wreckage, so in active lupus it falls rather than rises, the opposite of most markers on the panel.

Adult Male mg/dL
90
180

Consumed in active disease

Complement C4

C4

Read beside C3. A paired drop in both is the consumption pattern clinicians watch for when lupus is flaring.

Adult Male mg/dL
12
54

The RA branch

Rheumatoid Factor

RF

An antibody aimed at your own antibodies. Tied to rheumatoid arthritis by name, but positive in infections, other autoimmune disease, and healthy people, so it rarely stands alone.

Adult Male IU/mL
0
14

The vasculitis branch

p-ANCA

p-ANCA

A perinuclear-staining antibody against neutrophils, pointing toward a different group of vasculitides and sometimes inflammatory bowel disease.

Adult Male pattern absent / negative
0
0

The vasculitis branch

c-ANCA

c-ANCA

A cytoplasmic-staining antibody against neutrophils. The lab reports which ANCA type is present to help identify the form of autoimmune vasculitis.

Adult Male titer
0
20

Disease-specific antibody

Anti-SSA (Ro) Antibodies

Anti-SSA

Associated with Sjogren's disease and also seen in lupus. One of the named targets the extractable nuclear antigen panel breaks the ANA signal into.

Adult Male AI
0
0.9

Antiphospholipid Antibodies

aPL

Three antibodies tested together, reported as positive or negative. The surprise is how little a lone positive usually means and how much the full set does.

Adult Male negative / not detected
0
0

Anticardiolipin Antibodies

aCL

The antibody that can surface after a winter cold and be gone by spring, and why a single positive is the start of a question rather than an answer.

Adult Male GPL/MPL units
0
20

Total immunoglobulin

Immunoglobulin G

IgG

The most abundant antibody class overall. Tracked for the size of the total pool, a different question from any single autoantibody above.

Adult Male mg/dL
700
1600

Total immunoglobulin

Immunoglobulin A

IgA

A total antibody class, not a specific autoantibody. Measures the bulk of one immunoglobulin type rather than what it is aimed at.

Adult Male mg/dL
70
400

Disease-specific antibody

Anti-Centromere Antibodies

ACA

Classically tied to limited cutaneous scleroderma. Often the antibody behind a centromere staining pattern on the ANA screen.

Adult Male index
0
1

Lupus-specific

Anti-Double Stranded DNA

Anti-dsDNA

An antibody against your own double-stranded DNA, fairly specific for systemic lupus. A clear positive points toward lupus, and a rising level tends to track active disease.

Adult Male IU/mL
0
10

Disease-specific antibody

Anti-Jo-1 Antibodies

Anti-Jo-1

Linked to inflammatory myositis and the lung involvement that can travel with it. A specific clue rather than a screen.

Adult Male AI
0
1

The over-sensitive screen

Antinuclear Antibodies

ANA

Antinuclear antibodies, the panel's front door. Built to flag rather than miss, so it turns positive in many healthy people and reads as a question, not an answer. The titer and pattern decide what comes next.

Adult Negative (< 1:40)
0
0

Normal ranges at a glance

Test Normal range (Adult) Unit Flagged when
Anti-Smith Antibody Anti-Sm 0–0.9 index < 0 or > 0.9
Anti-Cyclic Citrullinated Peptide Anti-CCP 0–20 U/mL < 0 or > 20
Complement C3 C3 90–180 mg/dL < 90 or > 180
Complement C4 C4 12–54 mg/dL < 12 or > 54
Rheumatoid Factor RF 0–14 IU/mL < 0 or > 14
p-ANCA p-ANCA 0–0 pattern absent / negative < 0 or > 0
c-ANCA c-ANCA 0–20 titer < 0 or > 20
Anti-SSA (Ro) Antibodies Anti-SSA 0–0.9 AI < 0 or > 0.9
Antiphospholipid Antibodies aPL 0–0 negative / not detected < 0 or > 0
Anticardiolipin Antibodies aCL 0–20 GPL/MPL units < 0 or > 20
Immunoglobulin G IgG 700–1600 mg/dL < 700 or > 1600
Immunoglobulin A IgA 70–400 mg/dL < 70 or > 400
Anti-Centromere Antibodies ACA 0–1 index < 0 or > 1
Anti-Double Stranded DNA Anti-dsDNA 0–10 IU/mL < 0 or > 10
Anti-Jo-1 Antibodies Anti-Jo-1 0–1 AI < 0 or > 1
Antinuclear Antibodies ANA 0–0 Negative (< 1:40) < 0 or > 0

Representative adult reference ranges; intervals vary by laboratory and method, so the range printed on your own report always takes precedence. Each test links to its full sourcing.

Autoimmune Panel — Common Questions

Does a positive ANA on an autoimmune panel mean I have an autoimmune disease?
Usually not on its own. The American College of Rheumatology notes that only about 11 to 13 percent of people with a positive ANA turn out to have lupus or any autoimmune or connective tissue disease, and that up to 15 percent of completely healthy adults test positive. The screen is built to be over-sensitive so it rarely misses real disease, which is exactly why a positive is common and is read as a reason to look closer rather than a diagnosis.
What is the difference between the ANA and the specific antibodies like anti-dsDNA or anti-Smith?
They answer different questions. The ANA is a wide screen that asks whether your immune system is making antibodies against your own cell nuclei at all. The specific antibodies are narrower and each leans toward a particular disease: anti-dsDNA and anti-Smith toward lupus, anti-centromere toward limited scleroderma, anti-SSA toward Sjogren's. A positive ANA is the reason those specific tests get ordered; the specific results are what help name the condition.
Why would my complement C3 and C4 be low when my other autoimmune markers are high?
Because complement behaves differently from the antibodies. MedlinePlus describes complement proteins as being used up when the immune system is very active, so in a lupus flare C3 and C4 are consumed and fall while autoantibodies like anti-dsDNA climb. A paired drop in C3 and C4 alongside a rising anti-dsDNA is the pattern clinicians read as active disease, which is why these are ordered on the same draw.
What do c-ANCA and p-ANCA tell apart?
They are two staining types of the same family of anti-neutrophil antibodies, and per MedlinePlus the lab reports which one is present to help identify the type of autoimmune vasculitis. The two point toward different groups of vasculitis, and p-ANCA can also turn up in some inflammatory bowel disease. As with the rest of the panel, the antibody type narrows the question; the diagnosis rests on the wider picture your doctor assembles.
Do I need every marker on the panel run at once?
Often not. In practice the ANA is run first, and the specific antibodies, complement levels, and ANCA are added based on symptoms and on what the ANA shows. Bundled panels sometimes report everything together, but the markers were designed to be ordered as a cascade, with each result steering which test, if any, comes next. What gets checked is a clinician's call.

Related panels

INF

Inflammation Markers
CBC

Complete Blood Count (CBC)

Disclaimer

This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.